Healthcare Facilities company Krishna Institute of Medical Sciences announced Q3FY25 results Gross revenue of Rs 790 crore, a growth of 29.7% on YoY and 1.0% on QoQ basis. EBITDA of Rs 205 crore, a growth of 36.4% on YoY and de growth of 8.1% on QoQ basis. EBITDA margin at 25.9% vs 24.7% in Q3FY24 and 28.5% in Q2FY25. PAT at Rs 93 crore in Q3FY25 against Rs 77 crore and Rs 121 crore in Q3 FY24 and Q2FY25 respectively. Consolidated EPS for 9 months of Rs 7.1 (face value of shares Rs 2/-), a growth of 15.6% (adjusted for share split) on YoY basis. Cash and Cash Equivalents (includes Cash, Bank balance, Deposits with maturity less than 12 months and Investment in Mutual funds) at Rs 112 crore as on Q3FY25. B Bhaskar Rao, CMD, KIMS Hospitals, said: “Despite being a seasonally lean quarter, we have managed growth on key parameters like ARBOB and ARPP on a YoY basis. This has been possible because of our relentless focus on improving operational efficiencies. Going forward, as new units starts delivering on all parameters, we are confident of achieving our targets set for FY25 and beyond”. Result PDF